| Announce Date | 11/25/2025 |
| EPS Normalized Actual | $0.27 (Beat by $0.06) |
| EPS GAAP Actual | $0.27 (Beat by $0.06) |
| Revenue Actual | $0.108452B |
| Revenue Surprise | Beat by $108.452M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.027692 |
| EPS GAAP Estimate | $0.027692 |
| Revenue Estimate | $0.085311909B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2030 | 2.4 | 26.52 | 2.28207 | 2.5641 | 1 |
| Jan 2029 | 3.25 | 19.58 | 2.94424 | 3.5273 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.35 | -0.45931 | 0.108452B | 23.79% | 17.88M |
| FQ3 2025 (Jul 2025) | -0.47 | -0.394615 | 0.095511B | 33.28% | 19.12M |
| FQ2 2025 (Apr 2025) | -0.58 | -0.58 | 0.085872B | 36.56% | 85.87M |
| FQ1 2025 (Jan 2025) | -0.48 | -0.48 | 0.084015B | 38.56% | 84.02M |
| FQ4 2024 (Oct 2024) | 1.77 | 1.77 | 0.082653B | 100% | 82.65M |
| FQ3 2024 (Jul 2024) | -0.85 | -0.85 | 0.063724B | 100% | 63.72M |
| FQ2 2024 (Apr 2024) | -0.93 | -0.93 | 0.054473B | 100% | 54.47M |
| FQ1 2024 (Jan 2024) | -1.5 | -1.5 | 0.051616B | 100% | 51.62M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
0.027692
Consensus Revenue Estimates
0.085311909B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 0.17 | -- | 0.16996 | 0.17021 | 10 |
| FQ4 2027 (Oct 2027) | 0.2 | -- | 0.19996 | 0.20024 | 5 |
| FQ3 2027 (Jul 2027) | 0.14 | -- | 0.13997 | 0.14017 | 5 |
| FQ2 2027 (Apr 2027) | 0.09 | -- | 0.07989268 | 0.09549989 | 1 |
| FQ1 2027 (Jan 2027) | 0.17 | -- | 0.16574 | 0.17484 | 8 |
| FQ4 2026 (Oct 2026) | 0.36209 | 196.66 | 0.35394 | 0.37385 | 8 |
| FQ3 2026 (Jul 2026) | 0.22528 | 308.63 | 0.22021 | 0.2326 | 5 |
| FQ2 2026 (Apr 2026) | 0.11725 | 594.67 | 0.11461 | 0.12106 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 0.12B | -- | 0.12B | 0.12B | 4 |
| FQ4 2027 (Oct 2027) | 0.12B | -- | 0.12B | 0.12B | 10 |
| FQ3 2027 (Jul 2027) | 0.11B | -- | 0.11B | 0.11B | 7 |
| FQ2 2027 (Apr 2027) | 0.11B | -- | 0.1B | 0.11B | 5 |
| FQ1 2027 (Jan 2027) | 0.11B | -- | 0.1B | 0.11B | 5 |
| FQ4 2026 (Oct 2026) | 0.12B | 10.27 | 0.12B | 0.12B | 9 |
| FQ3 2026 (Jul 2026) | 0.11B | 11.25 | 0.11B | 0.11B | 6 |
| FQ2 2026 (Apr 2026) | 0.1B | 12.22 | 0.1B | 0.1B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.10931 | -0.35 | -0.45931 | 131.23% |
| FQ3 2025 (Jul 2025) | -0.075385 | -0.47 | -0.394615 | 83.96% |
| FQ2 2025 (Apr 2025) | -0.58 | -0.58 | 100% | |
| FQ1 2025 (Jan 2025) | -0.48 | -0.48 | 100% | |
| FQ4 2024 (Oct 2024) | 1.77 | 1.77 | 100% | |
| FQ3 2024 (Jul 2024) | -0.85 | -0.85 | 100% | |
| FQ2 2024 (Apr 2024) | -0.93 | -0.93 | 100% | |
| FQ1 2024 (Jan 2024) | -1.5 | -1.5 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.09B | $0.11B | $17.88M | 16.49% |
| FQ3 2025 (Jul 2025) | $0.08B | $0.1B | $19.12M | 20.02% |
| FQ2 2025 (Apr 2025) | $0B | $0.09B | $85.87M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $0.08B | $84.02M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.08B | $82.65M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.06B | $63.72M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.05B | $54.47M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.05B | $51.62M | 100% |